Dr. Gerschs Wissensarchiv | From Chronic Disease to Longevity
Dr. Gerschs Wissensarchiv | From Chronic Disease to Longevity
Transparenz-Hinweis (EU AI Act): Die Videoinhalte stammen zu 100% von Dr. Gersch oder seinem medizinischen Team. Das Titelbild und die Text-Zusammenfassungen wurden hingegen maschinell durch eine KI (Künstliche Intelligenz) generiert und sind nicht gesondert ärztlich überprüft.
Dr. Joris Deelen, a preeminent expert in Europe, has dedicated over a decade to the study of longevity markers. These markers, such as IGF-1, ApoE, and mTOR, hold significant promise in the scientific exploration of aging.
Biomarkers provide critical insights into the genetic and biochemical processes that influence human longevity. IGF-1 (Insulin-like Growth Factor 1) is an essential peptide, primarily associated with growth and development, and has connections to aging-related pathways.
Research has revealed its involvement in cellular replication and its influence on lifespan regulation.
ApoE, or Apolipoprotein E, plays a crucial role in lipid metabolism. Genetic variations in ApoE are linked to differences in disease risk, particularly neurodegenerative disorders, which can affect aging.
Dr. Deelen highlights the importance of this marker in understanding predispositions that come with aging.
mTOR (mechanistic Target of Rapamycin) is a central cellular growth regulator that responds to nutritional and energy cues.
It is pivotal in autophagy, metabolism, and the aging process. Modulating mTOR activity may offer pathways to delay aging and improve health span.
Dr. Deelen's contributions emphasize combining genetic and biochemical perspectives to piece together the complex puzzle of human aging.
Through examining these biomarkers, we can better understand the biological aging process and develop interventions to promote healthy aging.